109 related articles for article (PubMed ID: 12971387)
21. Indirubin derivatives inhibit Stat3 signaling and induce apoptosis in human cancer cells.
Nam S; Buettner R; Turkson J; Kim D; Cheng JQ; Muehlbeyer S; Hippe F; Vatter S; Merz KH; Eisenbrand G; Jove R
Proc Natl Acad Sci U S A; 2005 Apr; 102(17):5998-6003. PubMed ID: 15837920
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of constitutive STAT3 activity sensitizes resistant non-Hodgkin's lymphoma and multiple myeloma to chemotherapeutic drug-mediated apoptosis.
Alas S; Bonavida B
Clin Cancer Res; 2003 Jan; 9(1):316-26. PubMed ID: 12538484
[TBL] [Abstract][Full Text] [Related]
23. Resistance to small molecule inhibitors of epidermal growth factor receptor in malignant gliomas.
Li B; Chang CM; Yuan M; McKenna WG; Shu HK
Cancer Res; 2003 Nov; 63(21):7443-50. PubMed ID: 14612544
[TBL] [Abstract][Full Text] [Related]
24. New directions in cancer research 2003: technological advances in biology, drug resistance, and molecular pharmacology.
Franks ME; Macpherson GR; Lepper ER; Figg WD; Sparreboom A
Drug Resist Updat; 2003 Dec; 6(6):301-12. PubMed ID: 14744494
[TBL] [Abstract][Full Text] [Related]
25. Virtual screening of selective multitarget kinase inhibitors by combinatorial support vector machines.
Ma XH; Wang R; Tan CY; Jiang YY; Lu T; Rao HB; Li XY; Go ML; Low BC; Chen YZ
Mol Pharm; 2010 Oct; 7(5):1545-60. PubMed ID: 20712327
[TBL] [Abstract][Full Text] [Related]
26. American association for cancer research - 101st annual meeting - investigating new therapeutic candidates: part 2.
Mason VL
IDrugs; 2010 Jun; 13(6):360-2. PubMed ID: 20506053
[TBL] [Abstract][Full Text] [Related]
27. Progestins induce transcriptional activation of signal transducer and activator of transcription 3 (Stat3) via a Jak- and Src-dependent mechanism in breast cancer cells.
Proietti C; Salatino M; Rosemblit C; Carnevale R; Pecci A; Kornblihtt AR; Molinolo AA; Frahm I; Charreau EH; Schillaci R; Elizalde PV
Mol Cell Biol; 2005 Jun; 25(12):4826-40. PubMed ID: 15923602
[TBL] [Abstract][Full Text] [Related]
28. Novel targets for anticancer treatment development in colorectal cancer.
Macarulla T; Ramos FJ; Capdevila J; Saura C; Tabernero J
Clin Colorectal Cancer; 2006 Nov; 6(4):265-72. PubMed ID: 17241511
[TBL] [Abstract][Full Text] [Related]
29. HIF-1alpha, STAT3, CBP/p300 and Ref-1/APE are components of a transcriptional complex that regulates Src-dependent hypoxia-induced expression of VEGF in pancreatic and prostate carcinomas.
Gray MJ; Zhang J; Ellis LM; Semenza GL; Evans DB; Watowich SS; Gallick GE
Oncogene; 2005 Apr; 24(19):3110-20. PubMed ID: 15735682
[TBL] [Abstract][Full Text] [Related]
30. Grb2 regulates Stat3 activation negatively in epidermal growth factor signalling.
Zhang T; Ma J; Cao X
Biochem J; 2003 Dec; 376(Pt 2):457-64. PubMed ID: 14498832
[TBL] [Abstract][Full Text] [Related]
31. E-3810 is a potent dual inhibitor of VEGFR and FGFR that exerts antitumor activity in multiple preclinical models.
Bello E; Colella G; Scarlato V; Oliva P; Berndt A; Valbusa G; Serra SC; D'Incalci M; Cavalletti E; Giavazzi R; Damia G; Camboni G
Cancer Res; 2011 Feb; 71(4):1396-405. PubMed ID: 21212416
[TBL] [Abstract][Full Text] [Related]
32. Clinical trials referral resource. Flavopiridol.
Colevas D; Blaylock B; Gravell A
Oncology (Williston Park); 2002 Sep; 16(9):1204-5, 1210-2, 1214. PubMed ID: 12380947
[No Abstract] [Full Text] [Related]
33. The potential of Src inhibitors.
Elias D; Ditzel HJ
Aging (Albany NY); 2015 Oct; 7(10):734-5. PubMed ID: 26454527
[No Abstract] [Full Text] [Related]
34. PTK 787/ZK 222584, a tyrosine kinase inhibitor of all known VEGF receptors, represses tumor growth with high efficacy.
Hess-Stumpp H; Haberey M; Thierauch KH
Chembiochem; 2005 Mar; 6(3):550-7. PubMed ID: 15742376
[TBL] [Abstract][Full Text] [Related]
35. Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells.
Song L; Turkson J; Karras JG; Jove R; Haura EB
Oncogene; 2003 Jul; 22(27):4150-65. PubMed ID: 12833138
[TBL] [Abstract][Full Text] [Related]
36. The broad-range cyclin-dependent kinase inhibitor UCN-01 induces apoptosis in colon carcinoma cells through transcriptional suppression of the Bcl-x(L) protein.
Bhonde MR; Hanski ML; Magrini R; Moorthy D; Müller A; Sausville EA; Kohno K; Wiegand P; Daniel PT; Zeitz M; Hanski C
Oncogene; 2005 Jan; 24(1):148-56. PubMed ID: 15467762
[TBL] [Abstract][Full Text] [Related]
37. American Association for Cancer Research--96th Annual Meeting. Growth factor receptors.
Phillips T; Collins T; Davies J
IDrugs; 2005 Jun; 8(6):454-7. PubMed ID: 15906185
[No Abstract] [Full Text] [Related]
38. Cancer therapy finds a solid target.
Secko D
CMAJ; 2005 Aug; 173(3):246. PubMed ID: 16076816
[No Abstract] [Full Text] [Related]
39. Constitutive activation of Stat3 in fibroblasts transformed by diverse oncoproteins and in breast carcinoma cells.
Garcia R; Yu CL; Hudnall A; Catlett R; Nelson KL; Smithgall T; Fujita DJ; Ethier SP; Jove R
Cell Growth Differ; 1997 Dec; 8(12):1267-76. PubMed ID: 9419415
[TBL] [Abstract][Full Text] [Related]
40. Proline-, glutamic acid-, and leucine-rich protein-1 is essential in growth factor regulation of signal transducers and activators of transcription 3 activation.
Manavathi B; Nair SS; Wang RA; Kumar R; Vadlamudi RK
Cancer Res; 2005 Jul; 65(13):5571-7. PubMed ID: 15994929
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
